Clinical presentation | Radiographic presentation | Intraoperative findings Tumor localisation / Middle ear with extension to: | Follow up | ||
---|---|---|---|---|---|
Hearing loss 86.3% | CT | Mastoid | 18% | Mesotympanum 65% | Mean : 53 months [2-396] |
Aural fullness 33% | scan | EAC | 3% | Hypotympanum 53% | |
Tinnitus 27.6% | (68%) | Eustachian tube | 2% | Epitympanum 49% | Recurrence rate: 12.7% |
Otalgia 15% | Fallopian canal | 2 % | Aditus ad antrum 15% | Time for recurrence: 108 months | |
Otorhhea 11.4% | Jugular foramen | 2 % | Mastoid 15% | [13-516] | |
Facial weakness 11% | Tegmen antrilysis | < 1 % | Eustachian tube 7% | Local recurrence (N=8): 67% | |
Mean duraion of | MRI | Low to moderate signal | T1 | No precise description 20% | Local + regional recurrence (N=4): 33% |
symptoms: 38 | (13%) | High signal | T2 | Disease free from last treatment: | |
months | Enhancement | Contrast | 26 months [5-60] |